EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer

Sabine Groeger, Joerg Meyle iD

Periodontology 2000 · 2024-10 · 96 (1) · 150-169

DOI: 10.1111/prd.12548 ↗

At a glance

Übersichtsarbeit in Periodontology 2000, published online on 2024-02-13. Written by Sabine Groeger and 1 co-authors. Institution: Department of Periodontology, Dental School, Justus-Liebig-University of Giessen, Giessen, Germany. Major MEDLINE topics: B7-H1 Antigen, Periodontitis, Programmed Cell Death 1 Receptor, Epithelial-Mesenchymal Transition. Cited 19 times so far (Crossref); 229 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The programmed‐death‐ligand‐1 (PD‐L1) is an immune‐modulating molecule that is constitutively expressed on various immune cells, different epithelial cells and a multitude of cancer cells. It is a costimulatory molecule that may impair T‐cell mediated immune response. Ligation to the programmed‐death‐receptor (PD)‐1, on activated T‐cells and further triggering of the related signaling pathways can induce T‐cells apoptosis or anergy. The upregulation of PD‐L1 in various cancer types, including oral squamous cell carcinomas, was demonstrated and has been linked to immune escape of tumors and poor prognosis. A bidirectional relationship exists between the increased PD‐L1 expression and periodontitis as well as the epithelial–mesenchymal transition (EMT), a process of interconversion of epithelial cells to mesenchymal cells that may induce immune escape of tumors. Interaction between exosomal PD‐L1 and PD‐1 on T‐cells may cause immunosuppression by blocking the activation and proliferation of T‐cells. The efficacy and importance of treatment with PD‐1/PD‐L1 checkpoint inhibitors and their prognostic influence on human cancers was demonstrated. Regarding PD‐1/PD‐L1 checkpoint inhibitors, resistances exist or may develop, basing on various factors. Further investigations of the underlying mechanisms will help to overcome the therapeutic limitations that result from resistances and to develop new strategies for the treatment of cancer.

Subjects

MeSH terms (MEDLINE)

B7-H1 AntigenPeriodontitisProgrammed Cell Death 1 ReceptorEpithelial-Mesenchymal TransitionHumansNeoplasmsT-LymphocytesTumor EscapeImmune Checkpoint InhibitorsMouth Neoplasms

Author keywords

EMTPD‐L1cancerexosomesimmune checkpointimmune escapeperiodontitis

Substances

B7-H1 AntigenProgrammed Cell Death 1 ReceptorCD274 protein, humanImmune Checkpoint Inhibitors

Authors and institutions

  • Department of Periodontology, Dental School, Justus-Liebig-University of Giessen, Giessen, Germany.
  • Department of Orthodontics, Dental School, Justus-Liebig-University of Giessen, Giessen, Germany.

ORCID profiles: Joerg Meyle

Cite

APA

Groeger, S., & Meyle, J. (2024). The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer. Periodontology 2000, 96(1), 150-169. https://doi.org/10.1111/prd.12548

Vancouver

Groeger S, Meyle J. The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer. Periodontology 2000. 2024;96(1):150-169. doi:10.1111/prd.12548

BibTeX
@article{Groeger2024,
  author = {Groeger, Sabine and Meyle, Joerg},
  title = {The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer},
  journal = {Periodontology 2000},
  year = {2024},
  volume = {96},
  number = {1},
  pages = {150--169},
  doi = {10.1111/prd.12548}
}
Start for free →